Priority Date: 27.07.12 (EP 20120005485)

ORAL DOSAGE FORMS FOR MODIFIED RELEASE COMPRISING RUXOLITINIB

  • Application ID: EP13740041
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1891
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 27.07.2012 - Priority Date (EP 20120005485)
  • 30.01.2014 - Publication A1 (WO2014016396)
  • 03.06.2015 - Publication A1 (EP2877162)